| Descriptor English: | Antifibrotic Agents | ||||||
| Descriptor Spanish: |
Antifibróticos
| ||||||
| Descriptor Portuguese: | Antifibróticos | ||||||
| Descriptor French: | Antifibrotiques | ||||||
| Entry term(s): |
Agents, Anti-Fibrotic Anti-Fibrotic Agents |
||||||
| Tree number(s): |
D27.505.954.158.273 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000088962 | ||||||
| Scope note: | These agents are used to reduce FIBROSIS affecting organs and formation of scar TISSUES such as in SCLERODERMA patients. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Public MeSH Note: | 2022 |
||||||
| History Note: | 2022 |
||||||
| DeCS ID: | 59709 | ||||||
| Unique ID: | D000088962 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2022/01/01 | ||||||
| Date of Entry: | 2021/07/09 | ||||||
| Revision Date: | 2021/07/01 |
-
-
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
|
Antifibrotic Agents
- Preferred
| Concept UI |
M000742645 |
| Scope note | These agents are used to reduce FIBROSIS affecting organs and formation of scar TISSUES such as in SCLERODERMA patients. |
| Preferred term | Antifibrotic Agents |
| Entry term(s) |
Agents, Anti-Fibrotic Anti-Fibrotic Agents |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
